NOTES

Allergan, the Irvine health care company that specializes in eye and skin care products, said Tuesday that it has completed its acquisition of the assets of Oculinum Inc., a Berkeley-based manufacturer of biological products. The company would not disclose the purchase price. The transaction gives Allergan the right to manufacture, distribute and conduct research on the company’s Oculinum/BOTOX, which is used for treating muscle disorders in the eyes. Previously, Allergan only had a license to market the drug, which is being studied for treatment of juvenile cerebral palsy.